Organocatalyst treatment improves variant calling and mutant detection in archival clinical samples

Abstract Formalin fixation of biological specimens damages nucleic acids and limits their use in genomic analyses. Previously, we showed that RNA isolation with an organocatalyst (2-amino-5-methylphenyl phosphonic acid, used to speed up reversal of formalin-induced adducts) and extended heated incub...

Full description

Bibliographic Details
Main Authors: Leah C. Wehmas, Charles E. Wood, Ping Guan, Mark Gosink, Susan D. Hester
Format: Article
Language:English
Published: Nature Portfolio 2022-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-10301-0
_version_ 1818147512751489024
author Leah C. Wehmas
Charles E. Wood
Ping Guan
Mark Gosink
Susan D. Hester
author_facet Leah C. Wehmas
Charles E. Wood
Ping Guan
Mark Gosink
Susan D. Hester
author_sort Leah C. Wehmas
collection DOAJ
description Abstract Formalin fixation of biological specimens damages nucleic acids and limits their use in genomic analyses. Previously, we showed that RNA isolation with an organocatalyst (2-amino-5-methylphenyl phosphonic acid, used to speed up reversal of formalin-induced adducts) and extended heated incubation (ORGΔ) improved RNA-sequencing data from formalin-fixed paraffin-embedded (FFPE) tissue samples. The primary goal of this study was to evaluate whether ORGΔ treatment improves DNA-sequencing data from clinical FFPE samples. We isolated RNA and DNA ± ORGΔ from paired FFPE and frozen human renal and ovarian carcinoma specimens collected as part of the National Cancer Institute Biospecimen Pre-analytical Variables program. Tumor types were microscopically confirmed from adjacent tissue sections. Following extraction, DNA was fragmented and sequenced and differences were compared between frozen and FFPE sample pairs. Treatment with ORGΔ improved concurrent SNP calls in FFPE DNA compared to non-ORGΔ FFPE samples and enhanced confidence in SNP calls for all FFPE DNA samples, beyond that of matched frozen samples. In general, the concordant SNPs identified in paired frozen and FFPE DNA samples agreed for both genotype and homozygosity vs. heterozygosity of calls regardless of ORGΔ treatment. The increased confidence in ORGΔ FFPE DNA variant calls relative to the matched frozen DNA suggests a novel application of this method. With further optimization, this method may improve quality of DNA-sequencing data in FFPE as well as frozen tissue samples.
first_indexed 2024-12-11T12:36:26Z
format Article
id doaj.art-c82f8591c92b4bb0a366519a2cd4a31f
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-11T12:36:26Z
publishDate 2022-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-c82f8591c92b4bb0a366519a2cd4a31f2022-12-22T01:07:08ZengNature PortfolioScientific Reports2045-23222022-04-0112111010.1038/s41598-022-10301-0Organocatalyst treatment improves variant calling and mutant detection in archival clinical samplesLeah C. Wehmas0Charles E. Wood1Ping Guan2Mark Gosink3Susan D. Hester4Office of Research and Development, U.S. Environmental Protection AgencyOffice of Research and Development, U.S. Environmental Protection AgencyNational Cancer InstitutePfizerOffice of Research and Development, U.S. Environmental Protection AgencyAbstract Formalin fixation of biological specimens damages nucleic acids and limits their use in genomic analyses. Previously, we showed that RNA isolation with an organocatalyst (2-amino-5-methylphenyl phosphonic acid, used to speed up reversal of formalin-induced adducts) and extended heated incubation (ORGΔ) improved RNA-sequencing data from formalin-fixed paraffin-embedded (FFPE) tissue samples. The primary goal of this study was to evaluate whether ORGΔ treatment improves DNA-sequencing data from clinical FFPE samples. We isolated RNA and DNA ± ORGΔ from paired FFPE and frozen human renal and ovarian carcinoma specimens collected as part of the National Cancer Institute Biospecimen Pre-analytical Variables program. Tumor types were microscopically confirmed from adjacent tissue sections. Following extraction, DNA was fragmented and sequenced and differences were compared between frozen and FFPE sample pairs. Treatment with ORGΔ improved concurrent SNP calls in FFPE DNA compared to non-ORGΔ FFPE samples and enhanced confidence in SNP calls for all FFPE DNA samples, beyond that of matched frozen samples. In general, the concordant SNPs identified in paired frozen and FFPE DNA samples agreed for both genotype and homozygosity vs. heterozygosity of calls regardless of ORGΔ treatment. The increased confidence in ORGΔ FFPE DNA variant calls relative to the matched frozen DNA suggests a novel application of this method. With further optimization, this method may improve quality of DNA-sequencing data in FFPE as well as frozen tissue samples.https://doi.org/10.1038/s41598-022-10301-0
spellingShingle Leah C. Wehmas
Charles E. Wood
Ping Guan
Mark Gosink
Susan D. Hester
Organocatalyst treatment improves variant calling and mutant detection in archival clinical samples
Scientific Reports
title Organocatalyst treatment improves variant calling and mutant detection in archival clinical samples
title_full Organocatalyst treatment improves variant calling and mutant detection in archival clinical samples
title_fullStr Organocatalyst treatment improves variant calling and mutant detection in archival clinical samples
title_full_unstemmed Organocatalyst treatment improves variant calling and mutant detection in archival clinical samples
title_short Organocatalyst treatment improves variant calling and mutant detection in archival clinical samples
title_sort organocatalyst treatment improves variant calling and mutant detection in archival clinical samples
url https://doi.org/10.1038/s41598-022-10301-0
work_keys_str_mv AT leahcwehmas organocatalysttreatmentimprovesvariantcallingandmutantdetectioninarchivalclinicalsamples
AT charlesewood organocatalysttreatmentimprovesvariantcallingandmutantdetectioninarchivalclinicalsamples
AT pingguan organocatalysttreatmentimprovesvariantcallingandmutantdetectioninarchivalclinicalsamples
AT markgosink organocatalysttreatmentimprovesvariantcallingandmutantdetectioninarchivalclinicalsamples
AT susandhester organocatalysttreatmentimprovesvariantcallingandmutantdetectioninarchivalclinicalsamples